TP53 and neoplasm: The double knockout of Xrcc2 and Trp53 rescues embryonic lethality but leads to the development of multiple tumor types, including lymphomas, skin tumors, sarcomas and medulloblastomas, during early adulthood (~10 weeks), illustrating the fact that disrupting HR may induce a broad range of tumors [102].